Rhenman & Partners Asset Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-8,045
| Closed | -$1.01M | – | 101 |
|
|
2017
Q4 | $1.01M | Buy |
+8,045
| New | +$1.01M | 0.14% | 80 |
|
|
2017
Q3 | – | Sell |
-15,000
| Closed | -$2.14M | – | 114 |
|
|
2017
Q2 | $2.14M | Hold |
15,000
| – | – | 0.31% | 78 |
|
|
2017
Q1 | $2.76M | Hold |
15,000
| – | – | 0.44% | 73 |
|
|
2016
Q4 | $1.21M | Hold |
15,000
| – | – | 0.23% | 82 |
|
|
2016
Q3 | $1.15M | Hold |
15,000
| – | – | 0.18% | 87 |
|
|
2016
Q2 | $1.29M | Hold |
15,000
| – | – | 0.23% | 85 |
|
|
2016
Q1 | $1.39M | Buy |
15,000
+3,750
| +33% | +$347K | 0.28% | 82 |
|
|
2015
Q4 | $2.26M | Hold |
11,250
| – | – | 0.34% | 84 |
|
|
2015
Q3 | $1.68M | Buy |
11,250
+5,880
| +109% | +$878K | 0.27% | 84 |
|
|
2015
Q2 | $5.1M | Sell |
5,370
-730
| -12% | -$693K | 0.61% | 58 |
|
|
2015
Q1 | $4.47M | Buy |
+6,100
| New | +$4.47M | 0.75% | 46 |
|